We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.7B
AUM Growth
-$3.96B
Cap. Flow
-$1.66B
Cap. Flow %
-13.11%
Top 10 Hldgs %
14.02%
Holding
2,200
New
84
Increased
771
Reduced
1,166
Closed
158
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVRI icon
2001
Enviri
NVRI
$630M
$115K ﹤0.01%
16,267
+1,010
+7% +$9.1K
FF icon
2002
Future Fuel
FF
$229M
$113K ﹤0.01%
15,582
+1,275
+9% +$10.7K
GNT
2003
GAMCO Natural Resources, Gold & Income Trust
GNT
$142M
$111K ﹤0.01%
+23,686
New +$126K
UNIT
2004
Uniti Group
UNIT
$2.33B
$107K ﹤0.01%
11,286
-14,851
-57% -$172K
ZYME icon
2005
Zymeworks
ZYME
$1.7B
$106K ﹤0.01%
19,914
-799
-4% -$4.83K
BWCAW
2006
DELISTED
Blue Whale Acquisition Corp I Warrant
BWCAW
$105K ﹤0.01%
500,620
-874
-0.2% -$386
DHC
2007
Diversified Healthcare Trust
DHC
$2.11B
$104K ﹤0.01%
56,826
+3,825
+7% +$8.74K
ZYXI
2008
DELISTED
Zynex
ZYXI
$104K ﹤0.01%
+12,992
New +$92K
DHF
2009
BNY Mellon High Yield Strategies Fund
DHF
$172M
$103K ﹤0.01%
45,156
-39,297
-47% -$97.5K
GTPAW
2010
DELISTED
Gores Technology Partners, Inc. Warrant
GTPAW
$99K ﹤0.01%
479,997
CHRS icon
2011
Coherus Oncology
CHRS
$194M
$98K ﹤0.01%
13,480
-5,423
-29% -$47.2K
MAC icon
2012
Macerich
MAC
$6.66B
$95K ﹤0.01%
10,892
-12,245
-53% -$148K
PTON icon
2013
Peloton Interactive
PTON
$2.38B
$94K ﹤0.01%
10,253
+1,294
+14% +$20.8K
MAGN
2014
Magnera Corp
MAGN
$446M
$91K ﹤0.01%
1,011
+76
+8% +$9.11K
MSD
2015
Morgan Stanley Emerging Markets Debt Fund
MSD
$148M
$87K ﹤0.01%
13,093
-898
-6% -$6.46K
NRO
2016
Neuberger Real Estate Securities Income Fund Inc
NRO
$188M
$85K ﹤0.01%
22,240
+1,774
+9% +$7.64K
AWP
2017
abrdn Global Premier Properties Fund
AWP
$367M
$82K ﹤0.01%
5,575
+445
+9% +$7.29K
UA icon
2018
Under Armour Class C
UA
$2.67B
$80K ﹤0.01%
10,508
-32,095
-75% -$361K
VISN
2019
Vistance Networks Inc
VISN
$2.28B
$77K ﹤0.01%
+12,645
New +$88.4K
RXRAW
2020
DELISTED
RXR Acquisition Corp. Warrants to purchase Class A common stock
RXRAW
$77K ﹤0.01%
681,517
-2,462
-0.4% -$652
AMTX icon
2021
Aemetis
AMTX
$115M
$74K ﹤0.01%
+15,061
New +$132K
AFMD
2022
DELISTED
Affimed
AFMD
$73K ﹤0.01%
2,609
-36
-1% -$1.23K
BBBY
2023
DELISTED
Bed Bath & Beyond Inc
BBBY
$72K ﹤0.01%
14,425
+2,932
+26% +$34.1K
VRM icon
2024
Vroom Inc
VRM
$48.3M
$71K ﹤0.01%
711
-20
-3% -$2.51K
DBRG icon
2025
DigitalBridge
DBRG
$2.95B
$69K ﹤0.01%
3,541
-173,841
-98% -$4.24M

Similar funds

Guggenheim Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Guggenheim Capital held 2,200 positions worth $12.7B, down 24% from $16.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Guggenheim Capital withdrew a net $1.66B in Q2 2022, closing 158 positions and reducing 1,166 holdings. Its most notable exit was BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in ESAB worth $3.14M.

  • Guggenheim Capital's largest Q2 2022 buy was ESAB: 71,750 shares worth $3.14M.
  • Guggenheim Capital added most to Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q2 2022, an estimated $25.1M increase.
  • Guggenheim Capital's biggest Q2 2022 reduction was Apple, cutting an estimated $68.5M.
  • Guggenheim Capital fully exited BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC in Q2 2022, selling an estimated $13.1M.
  • Guggenheim Capital's ten largest holdings make up 14% of its $12.7B portfolio in Q2 2022.
  • Guggenheim Capital opened 84 new positions and closed 158 in Q2 2022.
  • Guggenheim Capital's portfolio value fell 24% quarter-over-quarter to $12.7B.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.